Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum

NeuroToxicology

Volumn 45, Issue , 2014, Pages 178-184

  Omonijo, Oluwaseyi ^a   Wongprayoon, Pawaris ^b   Ladenheim, Bruce ^a   McCoy, Michael T ^a   Govitrapong, Piyarat ^b   Jayanthi, Subramaniam ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Epigenetics; Gene expression; Neurotoxicity; Sirtuins

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 10; HISTONE DEACETYLASE 11; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE 9; MESSENGER RNA; METHAMPHETAMINE; SIRTUIN 2; SIRTUIN 5; SIRTUIN 6; MITOCHONDRIAL PROTEIN; SIRTUIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; HISTONE DEACETYLASE 10 GENE; HISTONE DEACETYLASE 11 GENE; HISTONE DEACETYLASE 6 GENE; HISTONE DEACETYLASE 8 GENE; HISTONE DEACETYLASE 9 GENE; HISTONE DEACETYLASE GENE; MALE; METHAMPHETAMINE DEPENDENCE; NEUROTOXICITY; NONHUMAN; RAT; ANIMAL; DRUG EFFECTS; METABOLISM; NEOSTRIATUM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; HISTONE DEACETYLASES; MALE; METHAMPHETAMINE; MITOCHONDRIAL PROTEINS; NEOSTRIATUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIRTUINS;

EID: 84910645297     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.10.008     Document Type: Article

References (81)

1. Afshar G., Murnane J.P. Characterization of a human gene with sequence homology to Saccharomyces cerevisiae SIR2. Gene 1999, 234:161-168.
2. Akhtar M.W., Kim M.S., Adachi M., Morris M.J., Qi X., Richardson J.A., et al. In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS ONE 2012, 7:e34863.
3. Balasubramanian S., Ramos J., Luo W., Sirisawad M., Verner E., Buggy J.J. A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia 2008, 22:1026-1034.
4. Bali P., Pranpat M., Bradner J., Balasis M., Fiskus W., Guo F., et al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 2005, 280:26729-26734.
5. Beauvais G., Atwell K., Jayanthi S., Ladenheim B., Cadet J.L. Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. PLoS ONE 2011, 6:e28946.
6. Beauvais G., Jayanthi S., McCoy M.T., Ladenheim B., Cadet J.L. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum. Brain Res 2010, 1318:1-10.
7. Boyault C., Zhang Y., Fritah S., Caron C., Gilquin B., Kwon S.H., et al. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev 2007, 21:2172-2181.
8. Brown J.M., Quinton M.S., Yamamoto B.K. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J Neurochem 2005, 95:429-436.
9. Buggy J.J., Sideris M.L., Mak P., Lorimer D.D., McIntosh B., Clark J.M. Cloning and characterization of a novel human histone deacetylase HDAC8. Biochem J 2000, 350(Pt 1):199-205.
10. Cadet J.L., Brannock C., Jayanthi S., Krasnova I.N. Transcriptional and epigenetic substrates of methamphetamine addiction and withdrawal: evidence from a long-access self-administration model in the rat. Mol Neurobiol 2014, [Epub ahead of print]. 10.1007/s12035-014-8776-8.
11. Cadet J.L., Jayanthi S., Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 2003, 17:1775-1788.
12. Cadet J.L., Jayanthi S., McCoy M.T., Beauvais G., Cai N.S. Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets 2010, 9:526-538.
13. Codd R., Braich N., Liu J., Soe C.Z., Pakchung A.A. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A. Int J Biochem Cell Biol 2009, 41:736-739.
14. de Jonge H.J., Fehrmann R.S., de Bont E.S., Hofstra R.M., Gerbens F., Kamps W.A., et al. Evidence based selection of housekeeping genes. PLoS ONE 2007, 2:e898.
15. de Leval L., Waltregny D., Boniver J., Young R.H., Castronovo V., Oliva E. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. Am J Surg Pathol 2006, 30:319-327.
16. Deng X., Ladenheim B., Tsao L.I., Cadet J.L. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 1999, 19:10107-10115.
17. Deng X., Wang Y., Chou J., Cadet J.L. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res 2001, 93:64-69.
18. Dietrich J.B. The MEF2 family and the brain: from molecules to memory. Cell Tissue Res 2013, 352:179-190.
19. Dion M.F., Altschuler S.J., Wu L.F., Rando O.J. Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci U S A 2005, 102:5501-5506.
20. Du J., Zhou Y., Su X., Yu J.J., Khan S., Jiang H., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809.
21. Finegersh A., Homanics G.E. Acute ethanol alters multiple histone modifications at model gene promoters in the cerebral cortex. Alcohol Clin Exp Res 2014, 38:1865-1873.
22. Flavell S.W., Cowan C.W., Kim T.K., Greer P.L., Lin Y., Paradis S., et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 2006, 311:1008-1012.
23. Flavell S.W., Kim T.K., Gray J.M., Harmin D.A., Hemberg M., Hong E.J., et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 2008, 60:1022-1038.
24. Gao L., Cueto M.A., Asselbergs F., Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 2002, 277:25748-25755.
25. Gertz M., Steegborn C. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in mammalia. Biochim Biophys Acta 2010, 1804:1658-1665.
26. Grozinger C.M., Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci U S A 2000, 97:7835-7840.
27. Guardiola A.R., Yao T.P. Molecular cloning and characterization of a novel histone deacetylase HDAC10. J Biol Chem 2002, 277:3350-3356.
28. Hayakawa T., Nakayama J. Physiological roles of class I HDAC complex and histone demethylase. J Biomed Biotechnol 2011, 2011:129383.
29. Hu E., Chen Z., Fredrickson T., Zhu Y., Kirkpatrick R., Zhang G.F., et al. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem 2000, 275:15254-15264.
30. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., et al. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417:455-458.
31. Jacobus J., Tapert S.F. Neurotoxic effects of alcohol in adolescence. Annu Rev Clin Psychol 2013, 9:703-721.
32. Jayanthi S., Deng X., Bordelon M., McCoy M.T., Cadet J.L. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J 2001, 15:1745-1752.
33. Jayanthi S., Deng X., Ladenheim B., McCoy M.T., Cluster A., Cai N.S., et al. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci U S A 2005, 102:868-873.
34. Jayanthi S., Deng X., Noailles P.A., Ladenheim B., Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 2004, 18:238-251.
35. Jayanthi S., McCoy M.T., Beauvais G., Ladenheim B., Gilmore K., Wood W., et al. Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum. PLoS ONE 2009, 4:e6092.
36. Jayanthi S., McCoy M.T., Chen B., Britt J.P., Kourrich S., Yau H.J., et al. Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms. Biol Psychiatry 2014, 76:47-56.
37. Kao H.Y., Lee C.H., Komarov A., Han C.C., Evans R.M. Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. J Biol Chem 2002, 277:187-193.
38. Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., Yao T.P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 2003, 115:727-738.
39. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
40. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009, 60:379-407.
41. Kuhn D.M., Francescutti-Verbeem D.M., Thomas D.M. Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity. Ann N Y Acad Sci 2008, 1139:118-126.
42. Lahm A., Paolini C., Pallaoro M., Nardi M.C., Jones P., Neddermann P., et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A 2007, 104:17335-17340.
43. Lee H., Rezai-Zadeh N., Seto E. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol Cell Biol 2004, 24:765-773.
44. Lee H., Sengupta N., Villagra A., Rezai-Zadeh N., Seto E. Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation. Mol Cell Biol 2006, 26:5259-5269.
45. Lee J.H., Jeong E.G., Choi M.C., Kim S.H., Park J.H., Song S.H., et al. Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells. Mol Cells 2010, 30:107-112.
46. Liu H., Hu Q., D'Ercole A.J., Ye P. Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells. Glia 2009, 57:1-12.
47. Liu H., Hu Q., Kaufman A., D'Ercole A.J., Ye P. Developmental expression of histone deacetylase 11 in the murine brain. J Neurosci Res 2008, 86:537-543.
48. Lyons M.R., Schwarz C.M., West A.E. Members of the myocyte enhancer factor 2 transcription factor family differentially regulate Bdnf transcription in response to neuronal depolarization. J Neurosci 2012, 32:12780-12785.
49. Mao Z., Tian X., Van Meter M., Ke Z., Gorbunova V., Seluanov A. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence. Proc Natl Acad Sci U S A 2012, 109:11800-11805.
50. Martin M., Kettmann R., Dequiedt F. Class IIa histone deacetylases: regulating the regulators. Oncogene 2007, 26:5450-5467.
51. Martin T.A., Jayanthi S., McCoy M.T., Brannock C., Ladenheim B., Garrett T., et al. Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens. PLoS ONE 2012, 7:e34236.
52. McCord R.A., Michishita E., Hong T., Berber E., Boxer L.D., Kusumoto R., et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany, NY) 2009, 1:109-121.
53. Mejat A., Ramond F., Bassel-Duby R., Khochbin S., Olson E.N., Schaeffer L. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. Nat Neurosci 2005, 8:313-321.
54. Melo P., Magalhaes A., Alves C.J., Tavares M.A., de Sousa L., Summavielle T., et al. Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory. Neurotoxicology 2012, 33:491-499.
55. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005, 16:4623-4635.
56. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124:315-329.
57. Mottet D., Castronovo V. Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 2008, 25:183-189.
58. Murr R. Interplay between different epigenetic modifications and mechanisms. Adv Genet 2010, 70:101-141.
59. Nahhas F., Dryden S.C., Abrams J., Tainsky M.A. Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol Cell Biochem 2007, 303:221-230.
60. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
61. Neugebauer R.C., Sippl W., Jung M. Inhibitors of NAD+ dependent histone deacetylases (sirtuins). Curr Pharm Des 2008, 14:562-573.
62. Newman J.C., He W., Verdin E. Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J Biol Chem 2012, 287:42436-42443.
63. North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003, 11:437-444.
64. O'Dell S.J., Weihmuller F.B., Marshall J.F. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem 1993, 60:1792-1799.
65. Oehme I., Linke J.P., Bock B.C., Milde T., Lodrini M., Hartenstein B., et al. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc Natl Acad Sci U S A 2013, 110:E2592-E2601.
66. Ogura M., Nakamura Y., Tanaka D., Zhuang X., Fujita Y., Obara A., et al. Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem Biophys Res Commun 2010, 393:73-78.
67. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
68. Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell 2013, 50:919-930.
69. Petrie K., Guidez F., Howell L., Healy L., Waxman S., Greaves M., et al. The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem 2003, 278:16059-16072.
70. Simoes-Pires C., Zwick V., Nurisso A., Schenker E., Carrupt P.A., Cuendet M. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?. Mol Neurodegener 2013, 8:7.
71. Sonsalla P.K., Gibb J.W., Hanson G.R. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 1986, 238:932-937.
72. Takase K., Oda S., Kuroda M., Funato H. Monoaminergic and neuropeptidergic neurons have distinct expression profiles of histone deacetylases. PLOS ONE 2013, 8:e58473.
73. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 2003, 983:84-100.
74. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., et al. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 2005, 25:5273-5279.
75. Tong J.J., Liu J., Bertos N.R., Yang X.J. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain. Nucleic Acids Res 2002, 30:1114-1123.
76. Vaquero A., Scher M.B., Lee D.H., Sutton A., Cheng H.L., Alt F.W., et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev 2006, 20:1256-1261.
77. Wang F., Nguyen M., Qin F.X., Tong Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007, 6:505-514.
78. Wang X., Tang X., Li M., Marshall J., Mao Z. Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival. J Biol Chem 2005, 280:16705-16713.
79. Wu J., Du C., Lv Z., Ding C., Cheng J., Xie H., et al. The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma. Dig Dis Sci 2013, 58:3545-3553.
80. Xu W., Zhu J.P., Angulo J.A. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 2005, 58:110-121.
81. Zhou X., Marks P.A., Rifkind R.A., Richon V.M. Cloning and characterization of a histone deacetylase HDAC9. Proc Natl Acad Sci U S A 2001, 98:10572-10577.